Obara I - Search Results

1

Inhibition of the mammalian target of rapamycin complex 1 signaling pathway reduces itch behaviour in mice.

Obara I, Medrano MC, Signoret-Genest J, Jiménez-Díaz L, Géranton SM, Hunt SP. Obara I, et al. Pain. 2015 Aug;156(8):1519-1529. doi: 10.1097/j.pain.0000000000000197. Pain. 2015. PMID: 25906350

2

Systemic inhibition of the mammalian target of rapamycin (mTOR) pathway reduces neuropathic pain in mice.

Obara I, Tochiki KK, Géranton SM, Carr FB, Lumb BM, Liu Q, Hunt SP. Obara I, et al. Pain. 2011 Nov;152(11):2582-2595. doi: 10.1016/j.pain.2011.07.025. Epub 2011 Sep 13. Pain. 2011. PMID: 21917376

3

Axonal protein synthesis and the regulation of primary afferent function.

Obara I, Hunt SP. Obara I, et al. Dev Neurobiol. 2014 Mar;74(3):269-78. doi: 10.1002/dneu.22133. Epub 2013 Nov 8. Dev Neurobiol. 2014. PMID: 24085547 Free PMC article. Review.

4

Nonparalytic botulinum molecules for the control of pain.

Mangione AS, Obara I, Maiarú M, Geranton SM, Tassorelli C, Ferrari E, Leese C, Davletov B, Hunt SP. Mangione AS, et al. Among authors: obara i. Pain. 2016 May;157(5):1045-1055. doi: 10.1097/j.pain.0000000000000478. Pain. 2016. PMID: 26761389 Free PMC article.

5

Axonal protein synthesis: a potential target for pain relief?

Obara I, Géranton SM, Hunt SP. Obara I, et al. Curr Opin Pharmacol. 2012 Feb;12(1):42-8. doi: 10.1016/j.coph.2011.10.005. Epub 2011 Oct 25. Curr Opin Pharmacol. 2012. PMID: 22033338 Free article. Review.

6

Synthetic self-assembling clostridial chimera for modulation of sensory functions.

Ferrari E, Gu C, Niranjan D, Restani L, Rasetti-Escargueil C, Obara I, Geranton SM, Arsenault J, Goetze TA, Harper CB, Nguyen TH, Maywood E, O'Brien J, Schiavo G, Wheeler DW, Meunier FA, Hastings M, Edwardson JM, Sesardic D, Caleo M, Hunt SP, Davletov B. Ferrari E, et al. Among authors: obara i. Bioconjug Chem. 2013 Oct 16;24(10):1750-9. doi: 10.1021/bc4003103. Epub 2013 Sep 20. Bioconjug Chem. 2013. PMID: 24011174 Free PMC article.

7

Nerve injury-induced changes in Homer/glutamate receptor signaling contribute to the development and maintenance of neuropathic pain.

Obara I, Goulding SP, Hu JH, Klugmann M, Worley PF, Szumlinski KK. Obara I, et al. Pain. 2013 Oct;154(10):1932-1945. doi: 10.1016/j.pain.2013.03.035. Epub 2013 Apr 2. Pain. 2013. PMID: 23685007 Free PMC article.

8

Spinal and local peripheral antiallodynic activity of Ro64-6198 in neuropathic pain in the rat.

Obara I, Przewlocki R, Przewlocka B. Obara I, et al. Pain. 2005 Jul;116(1-2):17-25. doi: 10.1016/j.pain.2005.03.012. Pain. 2005. PMID: 15927383

9

Inhibition of morphine tolerance by spinal melanocortin receptor blockade.

Starowicz K, Obara I, Przewłocki R, Przewlocka B. Starowicz K, et al. Among authors: obara i. Pain. 2005 Oct;117(3):401-411. doi: 10.1016/j.pain.2005.07.003. Pain. 2005. PMID: 16153779

10

Local peripheral opioid effects and expression of opioid genes in the spinal cord and dorsal root ganglia in neuropathic and inflammatory pain.

Obara I, Parkitna JR, Korostynski M, Makuch W, Kaminska D, Przewlocka B, Przewlocki R. Obara I, et al. Pain. 2009 Feb;141(3):283-291. doi: 10.1016/j.pain.2008.12.006. Epub 2009 Jan 14. Pain. 2009. PMID: 19147290

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters